Why the study?
Hypertension increases the risk of severe COVID-19 infection, making proper blood pressure control of great importance in these patients.
Do different classes of antihypertensive drugs affect outcomes in patients with COVID-19 and hypertension?
Do different classes of antihypertensive drugs affect outcomes in patients with COVID-19 and hypertension?
This review discusses the effects of various antihypertensive drug classes on patients with concurrent COVID-19 and hypertension.
Current data do not support changing antihypertensive regimens in COVID-19; leaves open need for prospective class-specific trials.
Hypertension is a major risk factor for cardiovascular disease. Previous studies showed that patients with hypertension are at an increased risk of developing severe COVID-19 infection. Therefore, proper blood pressure control in hypertensive patients with COVID-19 is of great importance. In this review, we discussed the effects of different classes of antihypertensive drugs on patients with hypertension and COVID-19.
No takes yet. Share an insight, caveat, or question.
Nozari et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: